preclinical

News

A white, pink-eyed mouse in surgical gloved hands

FDA publishes advice on animal testing alternatives

New draft guidance from the FDA is urging pharma companies to accelerate efforts to transition from animal testing to non-animal alternatives.

R&D

pharmaphorum podcast Episode 250, Rob DiCicco, Transcelerate

Making AI work where it matters, with Rob DiCicco

Rob DiCicco, vice president of portfolio management at Transcelerate Biopharma Inc, discusses barriers and the breakthroughs in making AI work.

News

FDA plans to phase out animal testing for antibodies

The FDA has said it intends to reduce or replace animal testing of some medicines, including monoclonal antibodies, with other methods.

News

BenchSci raises $50m to grow AI-powered R&D platform

Canadian firm BenchSci has secured around $50 million in third-round financing that will be used to speed up the adoption of its artificial intelligence-powered platform for biomedical rese

Partner Content

Partner Content

Medicines Discovery Catapult’s Discovery Services platform a...

Virtual R&D Discovery Services platform

Partner Content

Unrivalled imaging capabilities now available to accelerate ...

Unrivalled imaging capabilities now available

FDA publishes advice on animal testing alternatives

Making AI work where it matters, with Rob DiCicco

FDA plans to phase out animal testing for antibodies

BenchSci raises $50m to grow AI-powered R&D platform

Medicines Discovery Catapult’s Discovery Services platform a...

Unrivalled imaging capabilities now available to accelerate ...

Chiesi signs $1.9bn deal to buy KalVista and its HAE drug

Using AI-driven synthetic personas to take your insights fur...

preclinical

Editor's Picks